Kohlberg, Mubadala to acquire majority stake in PCI Pharma Services
Kohlberg & Company and Mubadala Investment have agreed to acquire a majority stake in drug development solutions provider…
Takeda to divest consumer healthcare business to Blackstone for $2.3bn
Japanese pharma giant Takeda Pharmaceutical has agreed to sell its consumer healthcare business to Oscar A-Co KK, a…
SAB Biotherapeutics begins phase 1b Covid-19 trial of SAB-185
SAB Biotherapeutics, a US biopharma company, said that the first patient in a phase 1b clinical trial of…
Janssen, Amgen secure FDA approval for DKd regiment in multiple myeloma
DKd regiment FDA approval for multiple myeloma : Janssen Pharmaceutical Companies of Johnson & Johnson and Amgen have…
Cipla, Stempeutics Research to launch Stempeucel for critical limb ischemia
Cipla announced that its partner Stempeutics Research has secured regulatory approval from the Drug Controller General of India…
Kazia Therapeutics gets fast track status for paxalisib in glioblastoma
Kazia Therapeutics, an Australian oncology company, has secured fast track designation (FTD) from the US Food and Drug…
Novartis bags Kesimpta FDA approval for relapsing forms of MS
Kesimpta FDA approval for RMS: Novartis has bagged approval from the US Food and Drug Administration (FDA) for…
Nipocalimab developer Momenta Pharmaceuticals to be acquired by J&J
J&J acquisition of Momenta Pharmaceuticals : US healthcare giant Johnson & Johnson (J&J) has signed a $6.5 billion…
Agilent Technologies to invest $150m to expand oligos production facility
Agilent Technologies said that it will invest nearly $150 million for the expansion of its oligos production facility…
Lilly, Innovent Biologics expand licensing deal for blood cancer drug Tyvyt
Eli Lilly and Company has signed an expanded licensing deal worth up to $1 billion with Chinese biotech…